References
- Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011, 3.
- Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477–485.
- Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 2004;122:487–494.
- Lee PP, Feldman ZW, Ostermann J, et al. Longitudinal prevalence of major eye diseases. Arch Ophthalmol 2003;121:1303–1310.
- Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA 2006;295:2158–2163.
- Kempen JH, O’Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552–563.
- Saaddine JB, Honeycutt AA, Narayan KM, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005–2050. Arch Ophthalmol 2008;126:1740–1747.
- Klein R, Klein BE, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864–2871.
- Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156–163.
- Rowe S, MacLean CH, Shekelle PG. Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA 2004;291:1487–1495.
- Group TDRSR. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88:583–600.
- Group ETDRSR. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796–1806.
- Committee AAoOPPP. Preferred practice pattern guidelines. Comprehensive adult medical eye evaluation. San Francisco, CA: American Academy of Ophthalmology, 2010.
- Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care 2003;26( Suppl. 1):S99–S102.
- Cavallerano J, Cooppan R. Optometric clinical practice guideline: care of the patient with diabetes mellitus. American Optometric Association 2002;243:63141–7881.
- Zhang X, Saaddine JB, Lee PP, et al. Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol 2007;125:411–418.
- Schoenfeld ER, Greene JM, Wu SY, et al. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001;108:563–571.
- Maclennan PA, McGwin G, Jr., Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospital’s clinics. JAMA Ophthalmol 2013;132:162–167.
- Bragge P, Gruen RL, Chau M, et al. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol 2011;129:435–444.
- Silva PS, Cavallerano JD, Aiello LM, et al. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol 2011;129:236–242.
- Williams GA, Scott IU, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111:1055–1062.
- Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965–971.